These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 26000707)
1. Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. Radwan MM; ElSohly MA; El-Alfy AT; Ahmed SA; Slade D; Husni AS; Manly SP; Wilson L; Seale S; Cutler SJ; Ross SA J Nat Prod; 2015 Jun; 78(6):1271-6. PubMed ID: 26000707 [TBL] [Abstract][Full Text] [Related]
2. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Linciano P; Citti C; Luongo L; Belardo C; Maione S; Vandelli MA; Forni F; Gigli G; Laganà A; Montone CM; Cannazza G J Nat Prod; 2020 Jan; 83(1):88-98. PubMed ID: 31891265 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154 [TBL] [Abstract][Full Text] [Related]
4. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ Citti C; Linciano P; Russo F; Luongo L; Iannotta M; Maione S; Laganà A; Capriotti AL; Forni F; Vandelli MA; Gigli G; Cannazza G Sci Rep; 2019 Dec; 9(1):20335. PubMed ID: 31889124 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol. DeLong GT; Wolf CE; Poklis A; Lichtman AH Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971 [TBL] [Abstract][Full Text] [Related]
6. Biologically active cannabinoids from high-potency Cannabis sativa. Radwan MM; Elsohly MA; Slade D; Ahmed SA; Khan IA; Ross SA J Nat Prod; 2009 May; 72(5):906-11. PubMed ID: 19344127 [TBL] [Abstract][Full Text] [Related]
7. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice. Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953 [TBL] [Abstract][Full Text] [Related]
8. Similarities and differences upon binding of naturally occurring Δ Raïch I; Rivas-Santisteban R; Lillo A; Lillo J; Reyes-Resina I; Nadal X; Ferreiro-Vera C; de Medina VS; Majellaro M; Sotelo E; Navarro G; Franco R Pharmacol Res; 2021 Dec; 174():105970. PubMed ID: 34758399 [TBL] [Abstract][Full Text] [Related]
9. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572 [TBL] [Abstract][Full Text] [Related]
10. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs. Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452 [TBL] [Abstract][Full Text] [Related]
11. Pure Δ Romano B; Pagano E; Orlando P; Capasso R; Cascio MG; Pertwee R; Marzo VD; Izzo AA; Borrelli F Pharmacol Res; 2016 Nov; 113(Pt A):199-208. PubMed ID: 27498155 [TBL] [Abstract][Full Text] [Related]
12. Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa). Pollastro F; Taglialatela-Scafati O; Allarà M; Muñoz E; Di Marzo V; De Petrocellis L; Appendino G J Nat Prod; 2011 Sep; 74(9):2019-22. PubMed ID: 21902175 [TBL] [Abstract][Full Text] [Related]
13. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors. Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877 [TBL] [Abstract][Full Text] [Related]
14. Minor oxygenated cannabinoids from high potency Cannabis sativa L. Ahmed SA; Ross SA; Slade D; Radwan MM; Khan IA; ElSohly MA Phytochemistry; 2015 Sep; 117():194-199. PubMed ID: 26093324 [TBL] [Abstract][Full Text] [Related]
15. Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences. Thomas BF; Lefever TW; Cortes RA; Grabenauer M; Kovach AL; Cox AO; Patel PR; Pollard GT; Marusich JA; Kevin RC; Gamage TF; Wiley JL J Pharmacol Exp Ther; 2017 Apr; 361(1):162-171. PubMed ID: 28087785 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor. Fischedick J; Van Der Kooy F; Verpoorte R Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579 [TBL] [Abstract][Full Text] [Related]